The SeriousTraders Newsletter If you are Serious about Trading, become a SeriousTrader!™

Oragenics Inc. (NYSE American: OGEN)

Investment Considerations Oragenics’ lead candidate, ONP-002, addresses a significant unmet medical need in concussion treatment with a stable, non-invasive delivery method that offers substantial market potential. The company’s proprietary intranasal delivery technology opens opportunities for expansion into multiple high-demand sectors, including neurology and infectious diseases. Oragenics’ ability to eliminate cold storage requirements for ONP-002 enhances … Continue reading “Oragenics Inc. (NYSE American: OGEN)”

View Profile